A detailed history of Intech Investment Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 135,500 shares of ADMA stock, worth $2.07 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
135,500
Previous 292,595 53.69%
Holding current value
$2.07 Million
Previous $5.81 Million 57.5%
% of portfolio
0.02%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

SELL
$17.6 - $24.51 $2.76 Million - $3.85 Million
-157,095 Reduced 53.69%
135,500 $2.47 Million
Q1 2025

May 20, 2025

BUY
$15.44 - $20.61 $2.81 Million - $3.75 Million
181,839 Added 164.18%
292,595 $5.81 Million
Q4 2024

Feb 10, 2025

BUY
$15.62 - $22.62 $759,694 - $1.1 Million
48,636 Added 78.29%
110,756 $1.9 Million
Q3 2024

Nov 08, 2024

BUY
$11.21 - $20.03 $696,365 - $1.24 Million
62,120 New
62,120 $1.24 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.